Primary tabs
The list of publications is indicative and may not include all publications.
Tenofovir alafenamide prophylaxis post-liver transplantation: a real-world study in patients with chronic kidney disease..
Acta Gastroenterol Belg. 85(2), 331-337.
(2022).
Enhanced recovery after surgery in liver transplantation: Challenges and feasibility..
World J Transplant. 12(7), 195-203.
(2022).
Effects of an active lifestyle on the physical frailty of liver transplant candidates..
World J Transplant. 12(11), 365-377.
(2022).
'Distribution of Hepatitis C Virus genotypes in northern Greece in the last decade: descriptive analysis and clinical correlations'..
Glob Health Epidemiol Genom. 4, e5.
(2019).
Is everolimus linked to metabolic syndrome in liver transplant recipients?.
Indian J Gastroenterol. 38(4), 348-355.
(2019).
Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe..
Lancet Gastroenterol Hepatol. 3(2), 125-133.
(2018).
Type 1 autoimmune hepatitis presenting with severe autoimmune neutropenia..
Ann Gastroenterol. 31(1), 123-126.
(2018).
An Unusual Cause of Haematemesis..
Eur J Vasc Endovasc Surg. 55(5), 656.
(2018).
Review article: Update on current and emergent data on hepatopulmonary syndrome..
World J Gastroenterol. 24(12), 1285-1298.
(2018).
Intravenous fosfomycin in patients with liver disease for extensively drug-resistant Gram-negative bacteria..
J Infect. 77(5), 448-454.
(2018).
Review article: Update on current and emergent data on hepatopulmonary syndrome.
World Journal of Gastroenterology. 24(12), 1285 - 1298.
(2018).
Hepatopulmonary syndrome is associated with the presence of hepatocellular carcinoma in patients with decompensated cirrhosis..
Ann Gastroenterol. 30(2), 225-231.
(2017).
Treatment of chronic hepatitis C with direct-acting antivirals in patients with β-thalassaemia major and advanced liver disease..
Br J Haematol. 178(1), 130-136.
(2017).
Comparison of creatinine and cystatin formulae with Chromium-ethylenediaminetetraacetic acid glomerular filtration rate in patients with decompensated cirrhosis..
J Gastroenterol Hepatol. 32(1), 191-198.
(2017).
High serum ferritin is associated with worse outcome of patients with decompensated cirrhosis..
Ann Gastroenterol. 30(2), 217-224.
(2017).
Renal function improvement in liver transplant recipients after early everolimus conversion: A clinical practice cohort study in Spain..
Liver Transpl. 22(1), 132-3.
(2016).
Nucleos(t)ide analogues for the prevention of hepatitis B recurrence after liver transplantation do not affect serum phosphorus levels..
Ann Gastroenterol. 29(2), 208-13.
(2016).
Nucleos(t)ide analog(s) prophylaxis after hepatitis B immunoglobulin withdrawal against hepatitis B and D recurrence after liver transplantation..
Transpl Infect Dis. 18(5), 667-673.
(2016).
On-treatment prediction of sustained response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B patients..
Liver Int. 35(5), 1540-8.
(2015).
Telbivudine is associated with improvement of renal function in patients transplanted for HBV liver disease..
J Viral Hepat. 22(7), 574-80.
(2015).
New nucleos(t)ide analogue monoprophylaxis after cessation of hepatitis B immunoglobulin is effective against hepatitis B recurrence..
Transpl Int. 27(10), 1022-8.
(2014).
Everolimus-based immunosuppression in liver transplant recipients: a single-centre experience..
Hepatol Int. 8(1), 137-45.
(2014).